| 000 | 01191 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250518010900.0 | ||
| 264 | 0 | _c20191219 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1002/cpt.1311 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTripaydonis, Anne | |
| 245 | 0 | 0 |
_aPediatric Anthracycline-Induced Cardiotoxicity: Mechanisms, Pharmacogenomics, and Pluripotent Stem-Cell Modeling. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _c03 2019 |
||
| 300 |
_a614-624 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnthracyclines _xadverse effects |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aCardiotoxins _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aPharmacogenetics _xtrends |
| 700 | 1 | _aConyers, Rachel | |
| 700 | 1 | _aElliott, David A | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 105 _gno. 3 _gp. 614-624 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt.1311 _zAvailable from publisher's website |
| 999 |
_c29075633 _d29075633 |
||